Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alzheimer's disease therapeutic vaccine
- Development stage
- Preclinical
- Lead developer
- Changchun BCHT Biotechnology
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Alzheimer's disease therapeutic vaccine is an investigational immunotherapy being developed by Changchun BCHT Pharmaceutical. Currently in the preclinical stage, the vaccine is designed to modulate the patient's immune system to target and clear pathological proteins associated with the progression of Alzheimer's disease. While the specific antigen target (such as amyloid-beta or tau protein) and the vaccine platform (e.g., peptide, DNA, or recombinant protein) have not been explicitly disclosed in the company's high-level pipeline, the program represents the company's expansion into chronic and neurodegenerative disease applications using its vaccine expertise.
- Other names
- 阿尔兹海默病治疗疫苗Alzheimer's disease therapeutic vaccine
02
Targets
Amyloid-beta aggregate (N-terminal epitope)p-tau (Phosphorylated microtubule-associated protein tau)
Beyond the preview
Go deeper on Alzheimer's disease therapeutic vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alzheimer's disease therapeutic vaccine.